HSDB 1430
HSDB 1430 Brand names, HSDB 1430 Analogs
- (+)-Aspartic acid
- (2S)-Aspartic acid
- (L)-ASPARTIC ACID
- (S)-Aminobutanedioic acid
- (S)-Aspartic acid
- 4-04-00-02998 (Beilstein Handbook Reference)
- AI3-04461
- Acide aspartique [INN-French]
- Acido aspartico [INN-Spanish]
- Acidum asparticum
- Acidum asparticum [INN-Latin]
- Aminosuccinic acid
- Asparagic acid
- Asparagic acid (VAN)
- Asparaginic acid
- Asparaginic acid (VAN)
- Asparaginsaeure [German]
- Aspartate
- Aspartate, L-
- Aspartic Acid [USAN:INN]
- Aspartic acid
- Aspartic acid (VAN)
- Aspartic acid, L-
- Aspatofort
- BRN 1723530
- Butanedioic acid, amino-, (S)-
- CCRIs 6181
- EINECS 200-291-6
- FEMA No. 3565
- H-Asp-OH
- HSDB 1430
- L( )-Aminobernsteinsaeure
- L-(+)-Aspartic acid
- L-2-Aminobutanedioic acid
- L-Aminosuccinic acid
- L-Asparagic acid
- L-Asparaginic acid
- L-Asparaginsaeure
- L-Asparaginsyra
- L-Aspartic acid
- L-Aspartinsaeure
- NSC 3973
HSDB 1430 Brand Names Mixture
- No information avaliable
HSDB 1430 Chemical_Formula
C4H7N1O4
HSDB 1430 RX_link
No information avaliable
HSDB 1430 fda sheet
HSDB 1430 msds (material safety sheet)
HSDB 1430 Synthesis Reference
No information avaliable
HSDB 1430 Molecular Weight
133.104 g/mol
HSDB 1430 Melting Point
230 oC
HSDB 1430 H2O Solubility
4.5 g/l
HSDB 1430 State
Solid
HSDB 1430 LogP
-0.67 +/- 0.36
HSDB 1430 Dosage Forms
Capsules and powder
HSDB 1430 Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
HSDB 1430 Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
HSDB 1430 Absorption
Absorbed from the small intestine by an active transport process
HSDB 1430 side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
HSDB 1430 Patient Information
No information avaliable
HSDB 1430 Organisms Affected
Humans and other mammals
